JP Stock MarketDetailed Quotes

4530 Hisamitsu Pharmaceutical

Watchlist
  • 4656.0
  • +612.0+15.13%
20min DelayMarket Closed Jan 10 15:30 JST
396.53BMarket Cap25.66P/E (Static)

Hisamitsu Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hisamitsu Pharmaceutical Q3 2025 Earnings Date

Currency：JPYJan 9, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
35.80B
--
-0.15%
EPS
--
62.21
--
+28.93%
Analyst Rating
Hold

Oct 22, 2024

Hisamitsu Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2027/Q1-- / 38.500B--
--2026/Q1-- / 37.000B--
Jan 9, 20252025/Q335.797B / ----
Jul 11, 20242025/Q135.810B / 36.500B--
Jan 11, 20242024/Q335.850B / ----
DatePeriodRevenue/EstimateEarnings Call
--2027/Q1-- / 38.500B--
--2026/Q1-- / 37.000B--
Jan 9, 20252025/Q335.797B / ----
Jul 11, 20242025/Q135.810B / 36.500B--
Jan 11, 20242024/Q335.850B / ----

Unlock Free Earnings Estimates

Hisamitsu Pharmaceutical Earnings Reports

  • Hisamitsu Pharmaceutical: Notice regarding revisions to earnings forecasts

    Jan 9 01:30 ET

  • Hisamitsu Pharmaceutical: Summary of Financial Results for the 3rd Quarter Ending February 2025 [Japanese GAAP] (Consolidated)

    Jan 9 01:30 ET

  • Hisamitsu Pharmaceutical: Confirmation letter

    Oct 11, 2024 02:12 ET

  • Hisamitsu Pharmaceutical: Semi-annual report - Period 123 (2024/03/01 - 2025/02/28)

    Oct 11, 2024 02:08 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 22, 2024

    Hold

    • Strong Buy

      0.00%

    • Buy

      0.00%

    • Hold

      100.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Price
    % Chg

    No Data